⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17190715 | 1.00 | — | — | |
| SCHEMBL15450247 | 0.79 | — | — | |
| SCHEMBL29493632 | 0.79 | — | — | |
| SCHEMBL21090429 | 0.78 | GAA (0.61) | — | |
| SCHEMBL17190707 | 0.77 | TSHR (0.42) | — | |
| SCHEMBL21806525 | 0.77 | CYP2D6 (0.39) | — | |
| SCHEMBL21806527 | 0.77 | CYP2D6 (0.39) | — | |
| SCHEMBL348301 | 0.75 | — | — | |
| SCHEMBL348302 | 0.75 | — | — | |
| Acetone SCHEMBL27953895 | 0.74 | MGAM (0.71) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10017605-B2 | Foam compositions | Gaco Western, LLC (US) | 2018-07-10 | — | — | US | disclosed |
| US-20160272754-A1 | FOAM COMPOSITIONS | AMRIZE TECHNOLOGY SWITZERLAND LLC (CH) | 2016-09-22 | — | — | US | disclosed |
| US-20160272754-A1 | FOAM COMPOSITIONS | AMRIZE TECHNOLOGY SWITZERLAND LLC (CH) | 2016-09-22 | — | — | US | disclosed |
| US-9359471-B2 | Foam compositions | Gaco Western, LLC (US) | 2016-06-07 | — | — | US | disclosed |
| US-20150299383-A1 | FOAM COMPOSITIONS | AMRIZE TECHNOLOGY SWITZERLAND LLC (CH) | 2015-10-22 | — | — | US | disclosed |
| US-7981950-B2 | Dispersant-encapsulated particulate solids | FUJIFILM IMAGING COLORANTS LIMITED (GB) | 2011-07-19 | — | — | US | disclosed |
| US-20070263050-A1 | Process | FUJIFILM IMAGING COLORANTS LIMITED (GB) | 2007-11-15 | — | — | US | disclosed |